Weill Cornell anesthesiologist appointed to commission on religious freedom

Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.

New tool empowers research on key proteins

A new single-protein analysis technique gives researchers an unprecedented ability to study scramblases, and could someday be useful in devising new strategies against multiple diseases.

Celebrating staff graduates, who balanced work and study

Ceremonies on Cornell’s Ithaca and Weill Cornell Medicine campuses honored not only academic achievement, but the resilience, shared purpose and commitment to lifelong learning that define Cornell staff.

Experimental treatment kills prostate tumor cells while reawakening antitumor immunity

Cornell Prime dots – known as C’ dots – are effective against prostate tumors, according to a new preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.

Metal-free carbon monoxide treatment may help prevent cancer’s deadly spread

A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment. 

Insular cortex linked to brain stimulation’s antidepressant effects

A circuit that runs from the prefrontal cortex to the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation, according to a study led by Weill Cornell Medicine investigators.

Protecting heart health in an era of temperature extremes

Extreme heat and cold are growing cardiovascular risks that can trigger heart attacks, strokes, heart failure and sudden cardiac death, according to a recent scientific statement by experts at Weill Cornell Medicine and other leading institutions.

A breakthrough single-cell method for mapping DNA-protein interactions

A new technology allows scientists to map the DNA-binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by Weill Cornell Medicine and the New York Genome Center.

Oral drug combination eases treatment burden for AML patients

A clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.